Terry2™ Band starting trial in Canada
Nanostent is pleased to announce that the team of nurses and interventional cardiologists at IUCPQ have started the EASY-RAO study.
To transform the art of medicine by developing disruptive technologies and miniaturized devices for the optimal care of patients.
Guided by a team with long-standing experience and contacts with daily practice, we are committed to timely deliver best in-class devices and technologies using a multidisciplinary design optimization approach.